In a report released today, Dylan Becker from William Blair maintained a Buy rating on Enfusion (ENFN – Research Report). The company’s shares opened today at $9.76.
According to TipRanks, Becker is a 3-star analyst with an average return of 4.7% and a 56.04% success rate. Becker covers the Technology sector, focusing on stocks such as Altair Engineering, Unity Software, and Blend Labs.
The word on The Street in general, suggests a Hold analyst consensus rating for Enfusion with a $10.50 average price target.
Based on Enfusion’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $46.49 million and a GAAP net loss of $1.13 million. In comparison, last year the company earned a revenue of $40.52 million and had a net profit of $5.75 million
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Enfusion (ENFN) Company Description:
Enfusion Inc is a software-as-a-service (SaaS) provider focused on transforming the investment management industry. Its solutions are designed to eliminate technology and information barriers, empowering investment managers to make and execute better-informed investment decisions in real-time. It simplifies investment and operational workflows by unifying mission-critical systems and coalescing data into a single dataset resulting in a single source of truth.
Read More on ENFN:
